Lesson
Separate the Event From the Disease
A seizure is an event. Epilepsy is an enduring predisposition. Acute symptomatic seizures demand cause-directed treatment before a chronic label is applied.
- Seizure
- Epilepsy
- Acute symptomatic
- Provoked
- Recurrence
seizure epilepsy
Trace the event from network physiology through classification, treatment, safety, and recovery.
Name the event precisely
A clinical seizure reflects transient abnormal excessive or synchronous neuronal activity. Epilepsy generally requires recurrent unprovoked seizures or a sufficiently high recurrence probability after one unprovoked seizure, interpreted in clinical context.
Find reversible drivers
Check glucose, sodium, calcium, magnesium, oxygenation, infection, stroke, trauma, toxic exposure, alcohol or sedative withdrawal, kidney and liver dysfunction, and medications that lower seizure threshold.
Do not confuse fever with epilepsy
Febrile seizures and other acute symptomatic events may not indicate a persistent epileptic disorder. Timing, age, syndrome features, cause, and recurrence risk guide follow-up.
Use harm reduction immediately
Until the diagnosis is clear, discuss driving and activity restrictions according to local rules, water and height safety, medication adherence, sleep, alcohol, and a plan for recurrent events.
Quick check
Lesson
Classify What the Evidence Can Support
The 2025 ILAE framework uses focal, generalized, unknown whether focal or generalized, and unclassified seizure classes, with consciousness and chronological semiology adding clinical precision.
- Focal
- Generalized
- Unknown
- Consciousness
- Semiology
classification diagnosis
Trace the event from network physiology through classification, treatment, safety, and recovery.
Use the current classes
Focal and generalized remain biologic classes. Unknown means the evidence cannot determine whether the seizure is focal or generalized. Unclassified means available information is inadequate for a more specific type.
Assess consciousness
For focal and unknown-class seizures, consciousness is classified through awareness and responsiveness. Document what was remembered and whether meaningful responses were possible.
Describe the sequence
Record observable and non-observable manifestations in chronological order, including sensory, autonomic, cognitive, emotional, behavioral, tonic, clonic, myoclonic, atonic, and postictal features.
Build the diagnostic story
Use patient and witness history, video when available, neurologic examination, EEG, MRI or CT when indicated, laboratory data, and differential diagnosis. A normal routine EEG does not exclude epilepsy.
Quick check
Lesson
Control Pathologic Firing at the Network
Antiseizure medications reduce repetitive firing, transmitter release, or excitation, or strengthen inhibition. Molecular mechanism informs therapy but does not replace clinical classification.
- Sodium channel
- Calcium channel
- GABA
- Glutamate
- SV2A
network pharmacology
Trace the event from network physiology through classification, treatment, safety, and recovery.
Limit high-frequency firing
Use-dependent sodium-channel modulation preferentially limits rapidly firing neurons. Agents differ in binding kinetics, slow inactivation, interactions, cardiac effects, and clinical spectrum.
Change transmitter release
Levetiracetam and brivaracetam bind SV2A and modulate synaptic vesicle release. Gabapentinoids bind alpha-2-delta calcium-channel subunits despite names that suggest direct GABA activity.
Strengthen inhibition
Benzodiazepines increase GABA-A chloride-channel opening frequency and barbiturates prolong opening. Rapid enhancement explains rescue efficacy and respiratory, cognitive, and sedation risk.
Target selected rhythms
Ethosuximide inhibits thalamic T-type calcium currents and is focused on absence seizures. Broad-spectrum drugs often combine several targets, which expands efficacy and adverse-effect burden.
Quick check
Lesson
Choose for the Seizure and the Person
The correct medication controls the patient's seizure type without creating a larger problem through mood, cognition, pregnancy risk, interactions, organ dysfunction, or an unusable formulation.
- Spectrum
- Syndrome
- Comorbidity
- Formulation
- Adherence
drug selection
Trace the event from network physiology through classification, treatment, safety, and recovery.
Classify before prescribing
Broad-spectrum options can cover focal and generalized epilepsies, while selected narrow-spectrum drugs can worsen some generalized seizure types. Syndrome and EEG features may materially change selection.
Use patient constraints
Review age, mood, cognition, weight, migraine, pain, kidney and liver function, bone health, cardiac disease, reproductive potential, occupation, driving, insurance, and ability to swallow or administer.
Prefer interpretable changes
Monotherapy simplifies attribution and adherence. Titrate according to urgency and product-specific risk, then measure seizure frequency, severity, rescue use, adverse effects, and function.
Recognize drug resistance
Failure of two tolerated, appropriately chosen and used medication schedules to achieve sustained seizure freedom should prompt specialist evaluation for surgery, neurostimulation, dietary therapy, and diagnostic reassessment.
Quick check
Lesson
Distinguish Broad-Spectrum Agents by Their Liabilities
Lamotrigine, levetiracetam, topiramate, and valproate cover multiple seizure types, but their titration, organ handling, interaction, cognitive, psychiatric, metabolic, and reproductive profiles differ sharply.
- Lamotrigine
- Levetiracetam
- Topiramate
- Valproate
- Titration
broad spectrum
Trace the event from network physiology through classification, treatment, safety, and recovery.
Respect lamotrigine titration
Slow titration limits serious-rash risk. Valproate inhibits lamotrigine metabolism and requires a lower schedule, while enzyme inducers increase clearance. A long interruption may require restarting titration.
Monitor levetiracetam behavior
Renal dose adjustment and direct assessment of irritability, aggression, depression, psychosis, somnolence, and coordination are essential despite minimal metabolic interactions.
Protect cognition and metabolism
Topiramate can impair language, attention, and memory and can cause weight loss, paresthesia, metabolic acidosis, kidney stones, reduced sweating, hyperthermia, and acute ocular reactions.
Use valproate only with full context
Valproate can be highly effective but carries hepatic failure, pancreatitis, thrombocytopenia, hyperammonemia, weight gain, mitochondrial disease, pregnancy, and neurodevelopmental risks.
Quick check
Lesson
Use Focused Agents Without Narrowing the Diagnosis
Carbamazepine-family agents, lacosamide, and ethosuximide can be excellent fits in selected seizures but require seizure-type, cardiac, genetic, sodium, and interaction safeguards.
- Carbamazepine
- Oxcarbazepine
- Lacosamide
- Ethosuximide
- HLA
focused agents
Trace the event from network physiology through classification, treatment, safety, and recovery.
Screen genetic hypersensitivity risk
Before carbamazepine in patients with ancestry associated with HLA-B*15:02, follow current labeling for testing. HLA-A*31:01 also informs hypersensitivity risk in relevant populations.
Watch sodium and interactions
Carbamazepine is a potent inducer with hematologic and hepatic risk. Oxcarbazepine and eslicarbazepine can cause clinically important hyponatremia and still affect contraceptive exposure.
Protect conduction
Lacosamide can prolong PR interval and requires attention to conduction disease and other conduction-slowing drugs. Dizziness and ataxia increase fall and driving risk.
Define ethosuximide's role
Ethosuximide is a focused treatment for absence seizures. When other generalized seizure types require control, a broader agent may be needed.
Quick check
Lesson
Interpret Exposure, Not Just the Reported Number
Phenytoin combines saturable metabolism, protein binding, nonlinear dose-concentration behavior, formulation constraints, and concentration-dependent neurologic toxicity.
- Saturation
- Albumin
- Free level
- Fosphenytoin
- Toxicity
phenytoin levels
Trace the event from network physiology through classification, treatment, safety, and recovery.
Expect nonlinearity
As phenytoin metabolism saturates, a small dose increase can cause a disproportionate concentration rise. Nystagmus, ataxia, slurred speech, confusion, and encephalopathy reflect increasing exposure.
Account for binding
Low albumin, kidney failure, critical illness, pregnancy, displacement, and interacting drugs can increase the unbound fraction. A measured free concentration is preferred when binding is substantially altered.
Use correction cautiously
Albumin-adjustment equations estimate exposure and are not substitutes for a free level when precision matters. Always interpret the result with timing, dose history, symptoms, and clinical response.
Distinguish products
Fosphenytoin is dosed in phenytoin equivalents and is used parenterally. Phenytoin salt and formulation differences can affect content, absorption, administration, and conversion.
Quick check
Lesson
Build a Safety Map Before the Prescription
Antiseizure therapy can change other drugs through induction or inhibition and can cause rash, mood change, hyponatremia, cytopenias, organ injury, bone effects, sedation, and falls.
- Induction
- Inhibition
- Rash
- Mood
- Organ function
interactions safety
Trace the event from network physiology through classification, treatment, safety, and recovery.
Map both interaction directions
Carbamazepine, phenytoin, phenobarbital, primidone, and related inducers can lower many substrates. Valproate can raise lamotrigine exposure. Estrogen-containing contraception can lower lamotrigine exposure.
Treat rash as a decision
Fever, mucosal involvement, facial edema, systemic symptoms, organ injury, or rapidly progressive rash requires urgent evaluation. Do not rechallenge casually after a serious hypersensitivity reaction.
Ask about mood and cognition
Monitor depression, suicidality, irritability, aggression, psychosis, sedation, and cognitive slowing. Family or caregiver observations can reveal changes the patient does not recognize.
Monitor drug-specific organs
Use sodium, bicarbonate, CBC, liver tests, kidney function, weight, vision, ECG, bone health, and drug concentrations selectively according to the chosen agent and patient.
Quick check
Lesson
Plan Before Pregnancy, Protect Control During Pregnancy
Reproductive care must reduce fetal medication risk without sacrificing seizure control, because convulsive seizures and abrupt medication changes can endanger both pregnant patient and fetus.
- Preconception
- Folate
- Valproate
- Concentration
- Postpartum
reproductive care
Trace the event from network physiology through classification, treatment, safety, and recovery.
Use the 2024 guideline
When appropriate to the epilepsy syndrome and patient, lamotrigine, levetiracetam, or oxcarbazepine should be considered to reduce major congenital-malformation risk. Valproate should be avoided when clinically feasible.
Supplement and counsel
Prescribe at least 0.4 mg folic acid daily before conception and during pregnancy for patients treated with an antiseizure medication. Discuss contraception, interactions, registry participation, lactation, and patient priorities.
Do not destabilize a pregnancy
Once pregnancy has begun, exercise caution when removing or replacing a medication that controls generalized tonic-clonic or focal-to-bilateral tonic-clonic seizures.
Follow changing clearance
Pregnancy can lower exposure to several agents, especially lamotrigine and levetiracetam. Establish an individual baseline when possible, monitor during pregnancy, and reduce pregnancy-related dose increases postpartum as clearance normalizes.
Quick check
Lesson
Treat the Clock as Brain
A convulsive seizure lasting five minutes or recurrent seizures without recovery requires immediate status-epilepticus treatment, not observation for the older 30-minute threshold.
- Five minutes
- Stabilization
- Benzodiazepine
- Second line
- Refractory
status epilepticus
Trace the event from network physiology through classification, treatment, safety, and recovery.
Stabilize in parallel
Protect airway and circulation, provide oxygen when needed, obtain access without delaying treatment, check glucose immediately, collect targeted laboratory data, and identify toxic, infectious, structural, metabolic, and adherence causes.
Give an adequate benzodiazepine
Use weight-appropriate IV lorazepam, IM midazolam, or an accepted alternative. A complete initial dose is more effective than repeated hesitant underdosing.
Load a second-line agent
If convulsions continue, accepted options include IV levetiracetam, fosphenytoin, or valproate, selected by patient-specific contraindications and logistics. Phenobarbital is an alternative in selected settings.
Escalate refractory disease
Persistent activity requires critical care, airway planning, continuous EEG, anesthetic therapy, and cause-directed treatment. Verify the actual dose and timing of every prior intervention.
Quick check
Lesson
Make the Rescue Plan Usable Under Stress
Seizure first aid prevents injury and community benzodiazepine rescue can interrupt defined clusters or prolonged seizures when the correct product, dose, technique, and escalation plan are available.
- Protect
- Position
- Time
- Intranasal
- Rectal
rescue first aid
Trace the event from network physiology through classification, treatment, safety, and recovery.
Protect without restraining
Clear hazards, ease the person to a safe surface, cushion the head, loosen restrictive clothing, turn to the side when feasible, and time the event. Do not restrain movement or place objects in the mouth.
Know when to call
Activate emergency services for a seizure lasting five minutes or longer, repeated seizures without recovery, breathing difficulty, serious injury, first known seizure, pregnancy, water exposure, or the patient's individualized action-plan threshold.
Choose the product deliberately
Diazepam rectal gel and intranasal diazepam or midazolam have product-specific ages, doses, second-dose rules, frequency limits, and administration steps. Use current labeling and the prescribed plan.
Prevent sedative stacking
Opioids, alcohol, and other CNS depressants increase sedation and respiratory risk with benzodiazepines. Caregivers must monitor breathing, responsiveness, response to rescue, and the emergency threshold.
Quick check
Lesson
Measure Freedom, Function, and Future Risk
Long-term success is not just a lower count. It includes seizure freedom, tolerability, cognition, mood, sleep, safety, adherence, reproductive goals, participation, and timely access to advanced care.
- Seizure diary
- SUDEP
- Driving
- Adherence
- Advanced care
longitudinal care
Trace the event from network physiology through classification, treatment, safety, and recovery.
Track interpretable outcomes
Record seizure type, timing, duration, recovery, triggers, missed doses, rescue use, injuries, menstrual or sleep relationships, adverse effects, and medication changes. Wearable data can support but not replace clinical interpretation.
Discuss SUDEP directly
Generalized tonic-clonic and focal-to-bilateral tonic-clonic seizure control is central to reducing SUDEP risk. Reinforce adherence, nocturnal and individualized safety, and prompt reporting of worsening control.
Protect daily life
Address driving law, water, heights, heat, machinery, sleep, alcohol, school, work, stigma, mental health, medication access, and an emergency plan without removing more independence than evidence requires.
Do not delay advanced evaluation
After failure of two appropriate tolerated regimens, refer for comprehensive epilepsy evaluation. Surgery, neurostimulation, dietary therapy, and diagnostic reconsideration can outperform indefinite medication accumulation.
Quick check
Module test
Check the connections.
Each attempt draws 10 questions from the complete 100 question bank.
Each attempt draws a fresh set and rearranges the answer choices.
References
Current clinical foundation.
Lecture material was synthesized with the following contemporary guidance. Verify local policy and current guidance before applying clinical information.
- RxPrep 2023 Seizures and Epilepsy chapter, printed pages 886 through 900
- ILAE: Updated classification of epileptic seizures, 2025
- AES: Treatment of convulsive status epilepticus
- AAN, AES, and SMFM: Antiseizure medication in pregnancy guideline, 2024
- FDA: Lamotrigine cardiac safety communication
- FDA: VALTOCO diazepam nasal spray labeling